.Nature Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin resulted in enhanced progression-free and also overall survival, causing FDA commendation and a new treatment choice for people.